Disclosure Of Cash Flow Statement [Text Block]

Embla Medical hf - Filing #5889952

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
Disclosure of cash flow statement [text block]
 
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
86,163,000 USD
72,653,000 USD
76,631,000 USD
Income taxes paid (refund) [abstract]
Income taxes paid (refund), classified as operating activities
23,487,000 USD
20,349,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.